Evidence map›Paper›PMID 36113111›Full record

SynthesisInterventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences2024

Observation versus intervention for Borden type I intracranial dural arteriovenous fistula: A pooled analysis of 469 patients.

Derrek Schartz, Redi Rahmani, Aditya Gunturi, Gurkirat Singh Kohli, Sajal Medha K Akkipeddi, Nathaniel R Ellens, Prasanth Romiyo, Alex Kessler, Tarun Bhalla, Thomas K Mattingly and 1 more

Abstract readMeta-AnalysisComparative Study
In one paragraph

Synthesis in Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Derrek SchartzDepartment of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-3247-0854
Redi RahmaniDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Aditya GunturiDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Gurkirat Singh KohliDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Sajal Medha K AkkipeddiDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Nathaniel R EllensDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Prasanth RomiyoDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Alex KesslerDepartment of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.
Tarun BhallaDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
Thomas K MattinglyDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0003-2949-5521
Matthew T BenderDepartment of Neurosurgery, University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile it is thought that Borden Type I intracranial dural arteriovenous fistula (dAVF) have a benign clinical course, their management remains controversial.

methodsA comparative meta-analysis was completed to evaluate the outcomes of intervention verses observation of Borden Type I intracranial dAVF. Outcome measures included: grade progression, worsening symptoms, death due to dAVF, permanent complications other than death, functional independence (mRS 0-2), and rate of death combined with permanent complication, were evaluated. Risk differences (RD) were determined using a random effects model.

resultsThree comparative studies combined with the authors' institutional experience resulted in a total of 469 patients, with 279 patients who underwent intervention and 190 who were observed. There was no significant difference in dAVF grade progression between the intervention and observation arms, 1.8% vs. 0.7%, respectively (RD: 0.01, 95% CI: -0.02 to 0.04,

conclusionIntervention of Borden Type I dAVF results in a higher risk of death or permanent complication, which should be strongly considered when deciding on management of these lesions.

Indexed as

Central Nervous System Vascular MalformationsDisease ProgressionEmbolization, TherapeuticHumansWatchful WaitingDural arteriovenous fistulaembolizationintracerebral hemorrhagevascular malformation

Identifiers

PMID36113111
PMCPMC11095342
OpenAlexW4295993133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.